Viste, Dylan
Rioux, William
Cristall, Nora
Orr, Taylor
Taplay, Pamela
Morris-Miller, Lisa
Ghosh, S. Monty
Funding for this research was provided by:
Health Canada’s Substance Use and Addictions Program (2122-HQ-000021, 2122-HQ-000021)
Canadian Institutes of Health Research (181006)
Article History
Received: 1 June 2023
Accepted: 12 September 2023
First Online: 27 September 2023
Declarations
:
: This study received University of Calgary research ethics board approval REB21-1966. All methods were carried out in accordance with relevant guidelines and regulations. Due to fact that participants are always anonymous on the NORS line, The need for informed consent was waived by the Ethics Committee/Institutional Review Board of the University of Calgary research ethics board.
: Not applicable.
: MG is a co-founder and advisor for NORS, receives funding from Health Canada’s Substance Use and Addiction Program, and is a board member with the Canadian Society of Addiction Medicine. DV receives salary funding via Health Canada’s Substance Use and Addiction Program, which provides operational funding for the National Overdose Response Service. WR receives salary funding from the Canadian Institute of Health Research. PT and LM are staff members of the National Overdose Response Service. LM and PT work for NORS. NC and TO are completely unaffiliated with NORS and are not paid for their contributions and have no competing interests.